Location History:
- San Diego, CA (US) (2013 - 2017)
- Vista, CA (US) (2022)
Company Filing History:
Years Active: 2013-2025
Title: Derren Barken: Innovator in Lupus Diagnosis and Treatment
Introduction
Derren Barken is a notable inventor based in San Diego, CA, who has made significant contributions to the field of medical diagnostics and treatment. With a total of 4 patents to his name, Barken's work primarily focuses on systemic lupus erythematosus (SLE), a complex autoimmune disease.
Latest Patents
Barken's latest patents include innovative methods for diagnosing and treating systemic lupus erythematosus. One of his patents discloses methods and reagents for diagnosing, prognosing, and treating SLE, which involve calculating an SLE risk score based on levels of various markers, including erythrocyte C4d (EC4d), B-cell C4d (BC4d), and anti-nuclear antibodies (ANA). Another patent expands on this by incorporating additional markers such as anti-Smith antibodies (anti-Sm) and optional rule-out markers like SS-B/La, Scl-70, Jo-1, CENP, and MCV.
Career Highlights
Throughout his career, Derren Barken has worked with prominent companies in the medical field, including Nestec S.A. and Exagen Inc. His expertise in the area of autoimmune diseases has positioned him as a valuable asset in the research and development of diagnostic tools and treatment methods.
Collaborations
Barken has collaborated with notable professionals in his field, including Thierry Dervieux and Fred Princen. These collaborations have further enhanced his research and contributed to the advancement of lupus diagnostics.
Conclusion
Derren Barken's innovative work in the diagnosis and treatment of systemic lupus erythematosus showcases his commitment to improving patient outcomes. His contributions to medical science are significant and continue to influence the field of autoimmune disease research.